Center for Blood Pressure Disorders, Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, 9500 Euclid Avenue, Q7 Glickman Tower, Cleveland, OH 44195, USA.
Cardiol Clin. 2019 Aug;37(3):307-317. doi: 10.1016/j.ccl.2019.04.006. Epub 2019 May 8.
Based on observational and clinical trials, formulation of hypertension guidelines began in 1977. Successive guideline reports recommended lower blood pressure goals, with emphasis shifting to treatment of systolic hypertension. In 2013, responsibility for hypertension guidelines was assigned to the American College of Cardiology and the American Heart Association. The new hypertension guideline was published in 2017, and the Systolic Blood Pressure Intervention Trial (SPRINT) informed many of the recommendations in the new guidelines. This article describes the SPRINT study results and the new guideline recommendations regarding hypertension management and blood pressure goals, with emphasis on chronic kidney disease and diabetes.
基于观察性和临床试验，高血压指南的制定始于 1977 年。随后的指南报告建议降低血压目标，重点转向治疗收缩期高血压。2013 年，美国心脏病学会和美国心脏协会负责高血压指南。新的高血压指南于 2017 年发布，收缩压干预试验（SPRINT）为新指南中的许多建议提供了信息。本文描述了 SPRINT 研究结果和新指南关于高血压管理和血压目标的建议，重点关注慢性肾脏病和糖尿病。
